J M G Larkin, M E Gore. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Antineoplastic Combined Chemotherapy Protocols/therapeutic useCarcinoma, Renal Cell/drug therapyCarcinoma, Renal Cell/mortalityHumansInterferon-alpha/administration & dosageInterleukin-2/administration & dosageKidney Neoplasms/drug therapyRandomized Controlled Trials as TopicSurvival AnalysisTime FactorsUnited Kingdom
Substances: See more » Interferon-alphaInterleukin-2
Year: 2005 PMID: 16097560 DOI: 10.1016/j.clon.2005.03.007
Source DB: PubMed Journal: Clin Oncol (R Coll Radiol) ISSN: 0936-6555 Impact factor: 4.126